Revision functional endoscopic sinus surgery: Objective and subjective surgical outcomes

K. Christopher McMains, Stilianos E Kountakis

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background: The aim of this study was to report objective and subjective outcomes after revision sinus surgery (RESS) for chronic rhinosinusitis (CRS). Methods: We performed a retrospective analysis of prospectively collected data in 125 patients requiring revision functional endoscopic sinus surgery after failing both maximum medical therapy and prior sinus surgery for CRS. Patients were seen and treated over a 3-year period (1999-2001) in a tertiary rhinology setting. Computed tomography (CT) scans were graded as per Lund-MacKay and patient symptom scores were recorded using the Sinonasal Outcome Test 20 (SNOT-20) instrument. Individual rhinosinusitis symptoms were evaluated on a visual analog scale (0-10) before and after surgery. All patients had a minimum 2-year follow-up. Results: The mean number of prior sinus procedures was 1.9 ± 0.1 (range, 1-7) and the mean preoperative CT grade was 13.4 ± 0.7 Patients with asthma and polyposis had higher CT scores than those without these processes. Preoperative mean SNOT-20 and endoscopy scores were 30.7 ± 1.3 and 7.3 ± 0.4, respectively. At the 2-year follow-up, mean SNOT-20 and endoscopy scores improved to 7.7 ± 0.6 and 2.1 ± 0.4, respectively (p < 2.8 × 10-10). At 12-month follow-up, each individual symptom score decreased significantly. Overall, 10 patients failed RESS and required additional surgical intervention for an overall failure rate of 8.0%. All patients who failed RESS had nasal polyposis. Conclusion: Revision functional endoscopic sinus surgery benefits patients that fail maximum medical therapy and prior sinus surgery for CRS by objective and subjective measures.

Original languageEnglish (US)
Pages (from-to)344-347
Number of pages4
JournalAmerican Journal of Rhinology
Volume19
Issue number4
StatePublished - Jul 1 2005

Fingerprint

Reoperation
Tomography
Endoscopy
Visual Analog Scale
Nose
Asthma
Therapeutics

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Revision functional endoscopic sinus surgery : Objective and subjective surgical outcomes. / McMains, K. Christopher; Kountakis, Stilianos E.

In: American Journal of Rhinology, Vol. 19, No. 4, 01.07.2005, p. 344-347.

Research output: Contribution to journalArticle

@article{b7c79df3ddaa4ada95af178ea1e984d1,
title = "Revision functional endoscopic sinus surgery: Objective and subjective surgical outcomes",
abstract = "Background: The aim of this study was to report objective and subjective outcomes after revision sinus surgery (RESS) for chronic rhinosinusitis (CRS). Methods: We performed a retrospective analysis of prospectively collected data in 125 patients requiring revision functional endoscopic sinus surgery after failing both maximum medical therapy and prior sinus surgery for CRS. Patients were seen and treated over a 3-year period (1999-2001) in a tertiary rhinology setting. Computed tomography (CT) scans were graded as per Lund-MacKay and patient symptom scores were recorded using the Sinonasal Outcome Test 20 (SNOT-20) instrument. Individual rhinosinusitis symptoms were evaluated on a visual analog scale (0-10) before and after surgery. All patients had a minimum 2-year follow-up. Results: The mean number of prior sinus procedures was 1.9 ± 0.1 (range, 1-7) and the mean preoperative CT grade was 13.4 ± 0.7 Patients with asthma and polyposis had higher CT scores than those without these processes. Preoperative mean SNOT-20 and endoscopy scores were 30.7 ± 1.3 and 7.3 ± 0.4, respectively. At the 2-year follow-up, mean SNOT-20 and endoscopy scores improved to 7.7 ± 0.6 and 2.1 ± 0.4, respectively (p < 2.8 × 10-10). At 12-month follow-up, each individual symptom score decreased significantly. Overall, 10 patients failed RESS and required additional surgical intervention for an overall failure rate of 8.0{\%}. All patients who failed RESS had nasal polyposis. Conclusion: Revision functional endoscopic sinus surgery benefits patients that fail maximum medical therapy and prior sinus surgery for CRS by objective and subjective measures.",
author = "McMains, {K. Christopher} and Kountakis, {Stilianos E}",
year = "2005",
month = "7",
day = "1",
language = "English (US)",
volume = "19",
pages = "344--347",
journal = "American Journal of Rhinology and Allergy",
issn = "1945-8924",
publisher = "OceanSide Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Revision functional endoscopic sinus surgery

T2 - Objective and subjective surgical outcomes

AU - McMains, K. Christopher

AU - Kountakis, Stilianos E

PY - 2005/7/1

Y1 - 2005/7/1

N2 - Background: The aim of this study was to report objective and subjective outcomes after revision sinus surgery (RESS) for chronic rhinosinusitis (CRS). Methods: We performed a retrospective analysis of prospectively collected data in 125 patients requiring revision functional endoscopic sinus surgery after failing both maximum medical therapy and prior sinus surgery for CRS. Patients were seen and treated over a 3-year period (1999-2001) in a tertiary rhinology setting. Computed tomography (CT) scans were graded as per Lund-MacKay and patient symptom scores were recorded using the Sinonasal Outcome Test 20 (SNOT-20) instrument. Individual rhinosinusitis symptoms were evaluated on a visual analog scale (0-10) before and after surgery. All patients had a minimum 2-year follow-up. Results: The mean number of prior sinus procedures was 1.9 ± 0.1 (range, 1-7) and the mean preoperative CT grade was 13.4 ± 0.7 Patients with asthma and polyposis had higher CT scores than those without these processes. Preoperative mean SNOT-20 and endoscopy scores were 30.7 ± 1.3 and 7.3 ± 0.4, respectively. At the 2-year follow-up, mean SNOT-20 and endoscopy scores improved to 7.7 ± 0.6 and 2.1 ± 0.4, respectively (p < 2.8 × 10-10). At 12-month follow-up, each individual symptom score decreased significantly. Overall, 10 patients failed RESS and required additional surgical intervention for an overall failure rate of 8.0%. All patients who failed RESS had nasal polyposis. Conclusion: Revision functional endoscopic sinus surgery benefits patients that fail maximum medical therapy and prior sinus surgery for CRS by objective and subjective measures.

AB - Background: The aim of this study was to report objective and subjective outcomes after revision sinus surgery (RESS) for chronic rhinosinusitis (CRS). Methods: We performed a retrospective analysis of prospectively collected data in 125 patients requiring revision functional endoscopic sinus surgery after failing both maximum medical therapy and prior sinus surgery for CRS. Patients were seen and treated over a 3-year period (1999-2001) in a tertiary rhinology setting. Computed tomography (CT) scans were graded as per Lund-MacKay and patient symptom scores were recorded using the Sinonasal Outcome Test 20 (SNOT-20) instrument. Individual rhinosinusitis symptoms were evaluated on a visual analog scale (0-10) before and after surgery. All patients had a minimum 2-year follow-up. Results: The mean number of prior sinus procedures was 1.9 ± 0.1 (range, 1-7) and the mean preoperative CT grade was 13.4 ± 0.7 Patients with asthma and polyposis had higher CT scores than those without these processes. Preoperative mean SNOT-20 and endoscopy scores were 30.7 ± 1.3 and 7.3 ± 0.4, respectively. At the 2-year follow-up, mean SNOT-20 and endoscopy scores improved to 7.7 ± 0.6 and 2.1 ± 0.4, respectively (p < 2.8 × 10-10). At 12-month follow-up, each individual symptom score decreased significantly. Overall, 10 patients failed RESS and required additional surgical intervention for an overall failure rate of 8.0%. All patients who failed RESS had nasal polyposis. Conclusion: Revision functional endoscopic sinus surgery benefits patients that fail maximum medical therapy and prior sinus surgery for CRS by objective and subjective measures.

UR - http://www.scopus.com/inward/record.url?scp=25144457085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144457085&partnerID=8YFLogxK

M3 - Article

C2 - 16171166

AN - SCOPUS:25144457085

VL - 19

SP - 344

EP - 347

JO - American Journal of Rhinology and Allergy

JF - American Journal of Rhinology and Allergy

SN - 1945-8924

IS - 4

ER -